(Q40605372)

22 September 2017

title

Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma (English)

1 reference

22 September 2017

1 reference

Yoshinaga K

1

1 reference

22 September 2017

Teramura M

2

1 reference

22 September 2017

Iwabe K

3

1 reference

22 September 2017

Kobayashi S

4

1 reference

22 September 2017

Masuda M

5

1 reference

22 September 2017

Motoji T

6

1 reference

22 September 2017

Mizoguchi H

7

1 reference

22 September 2017

publication date

1 March 2001

1 reference

American Journal of Hematology

22 September 2017

published in

1 reference

22 September 2017

volume

66

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

220-223

1 reference

Antipyretic effect of indomethacin in patients with malignancy

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Spontaneous remission in diffuse large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Biphenotypic B/macrophage cells express COX-1 and up-regulate COX-2 expression and prostaglandin E(2) production in response to pro-inflammatory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Naproxen has greater antipyretic effect on Hodgkin's disease-related fever than no other tumours or infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Spontaneous regression in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

Phenylbutazone (butazolidin) in the treatment of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

10.1002/1096-8652(200103)66:3<220::AID-AJH1048>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference